Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Psilocybin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 Breast 1

Conditions

Interventions

Cyclophosphamide 12 fludarabine phosphate 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Mycophenolic Acid 6 Biopsy 6 fludarabine 5 Tacrolimus 5 Melphalan 5 Educational Status 5 Early Intervention, Educational 5 Decitabine 5 Cyclosporine 5 Carboplatin 5 Antilymphocyte Serum 5 Aminolevulinic Acid 5 Sulindac 4 Radiotherapy 4 Patient Reported Outcome Measures 4 Methotrexate 4 Methods 4 Colposcopy 4 Celecoxib 4 Capecitabine 4 toripalimab 3 Sirolimus 3 Selenium 3 Polymerase Chain Reaction 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡